Pages
Ads
Categories
- Allergies pills
- Anthelmintics
- Anti Convulsants Pills
- Anti Depressants Pills
- Antibiotics Pills
- AntiViralPill
- Arthritis pills
- Blood Pressure Pills
- Cholesterol Pills
- Diabetes Pills
- Diuretics pills
- eBook download
- Erectile Dysfunction Pills
- Gastrointestinal Pills
- Heartburn Pills
- herbal
- Hypertension pills
- Images pills
- Inflammatory
- Mens Health pills
- Muscle Relaxant Pills
- News
- Other pills
- Pain Relief Pills
- Review prices
- Skin Care Pills
- Stop Smoking Pills
- Uncategorized
- Video about ED pills
- Weight Loss Pills
- Women's Health Drugs
Blogroll
- Acne Treatment Tips
- Acomplia blog
- Advanced whois
- Cialis vs Levitra
- Diet Recipes Blog
- Flexyx A-Z drugs
- Generic Cialis soft tabs
- Home Health Agencies
- Learn How to Overcome Depression
- Safe Net Pharmacy
- Traumatology and Orthopaedics
- Viagra
- Stiefel Receives US FDA Approval of Fabior Foam, 0.1%
- MEDA Announces Dymista Approved by the FDA
- FDA Approves New Orphan Drug Elelyso to Treat a Form of Gaucher Disease
- FDA Approves Levaquin as an Antibacterial Treatment for Plague
- FDA Approves Stendra for Erectile Dysfunction
- FDA Approves Votrient for Advanced Soft Tissue Sarcoma
- Novartis drug Afinitor approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
- Victoza Label Updated to Include Data Showing Superior Efficacy When Compared to Januvia
- FDA Approves Amyvid (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
- Neupro Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome
Tags
ads
The First Miracle Drugs
May 11, 2008
On Christmas Day 1932, the German chemical combine I.G. Farbenindustrie
filed a patent application on behalf of a red dye that its medical researchers
and chemists had found to have a remarkable ability to cure certain kinds of bac-
terial infections in mice. By the time the patent was awarded just over two years
later, the dye, now called by the trade name Prontosil, had been found to have the
same curative powers in humans. Announced in a brief publication in a German
medical journal in February 1935 by Gerhard Domagk, the medical researcher re-
sponsible for the work, Prontosil went on the market and became available to doc-
tors in April 1935.
In retrospect, it is clear that the introduction of Prontosil marked a turning
point in the history of medicine. As the first of the compounds called sulfon-
amides or, more familiarly, sulfa drugs, Prontosil initiated a revolution in the ther-
apeutics and management of bacterial infections. Within a few years, feared
diseases such as streptococcal infections (including childbed fever and sep-
ticemia), pneumonia, meningitis, dysentery, gonorrhea, and urinary tract infec-
tions, were brought under a substantial measure of control by chemotherapy. The
medical success of the sulfa drugs gave a powerful impetus to the expansion of the
international pharmaceutical industry and of the research and development enter-
prise within it….
Posted in: eBook download | |
No Comments »
No comments yet.
Fatal error: Call to undefined function post_comments_feed_link() in /var/www/viptabs/data/www/news.drugrxus.com/wp-content/themes/apple/comments.php on line 29